7:45-8:45 a.m.
Routine or Selective Use of New Lesion Assessments: IVUS and FFR
Moderators: Srihari Naidu, Mineola, N.Y., and Roxana Mehran, New York, N.Y.

Practical Aspects and Pitfalls in FFR Assessment - William Fearon, Stanford, Calif.

IVUS and Virtual Histology: Routine or Selective? - Martin Leon, New York, N.Y.

9-10:15 a.m.
Drug Eluting Stents: 2009 Update
Moderators: Donald E. Cutlip, Boston, Mass., and Renu Virmani, Gaithersburg, Md.

Dual Anti-Platelet Therapy Duration after DES: The Complexities of a Randomized Trial - Laura Mauri, Boston, Mass.

New DES Clinical Development. What Can We Expect? - Gregg W Stone, New York, N.Y.

Drug Responsiveness and Management of Anti-Platelet Therapy after DES. Why the Resistance to Testing? - Paul Gurbel, Baltimore, Md.

Late Safety of the Second Generation Everolimus and Zotarolimus Eluting Stents - Stephan Windecker, Bern, Switzerland

Temporal Trends in DES Outcomes from the Swedish Registry - Stefan K James, Durham, N.C.

10:45 a.m.-Noon
Iliac and Femoral Interventions: From Basics to New Approaches ▪ (Ask the Experts)
Moderators: Michael J. Rinaldi, Charlotte, N.C. and Manesh R. Patel, Hillsborough, N.C.

Case Presenter: Michael J. Rinaldi, Charlotte, N.C.

Panel Discussion: Thomas Zeller, Bad Krozingen, Germany, Kenneth Rosenfield, Boston, Mass., Michael Bettmann, Winston-Salem, N.C., and Barry T. Katzen, Miami, Fla.

2-3:15 p.m.
Industry, FDA, Journals, Senators and Interventional Cardiologists

3:45-5 p.m.
Revascularization for Multivessel CAD: State of the Art
Moderators: John Ikonomidis, Charleston, S.C., and David Holmes, Rochester, Minn.

SYNTAX Demonstrates the Potential for Multivessel PCI - Marie Morice, Massy, France

New Insights in PCI for Left Main Disease - Patrick W. Serruys, Rotterdam, Netherlands

5:30-6:45 p.m.
Improving PCI and AMI Quality: Key Insights from Observational Studies

Moderators: Harold Dauerman, Burlington, Vt. and Eric D. Peterson, Durham, N.C.

Insights into Operator and Institution Volumes and Outcomes - V.S Srinivas, Bronx, N.Y.

Mission Lifeline: Impact on STEMI PCI Outcomes - Timothy Henry, Minneapolis, Minn.

Can Registry Involvement Really Improve PCI Quality? - David Malenka, Lebanon, N.H. 

The Next Frontier: Can We, Payors and Registries Judge PCI Approptiateness? - Manesh R. Patel, Hillsborough, N.C.